BDBM50220013 (5R)-3-{3-fluoro-4-[6-(piperidin-4-ylacetyl)pyridin-3-yl]phenyl}-5-(1H-1,2,3-triazol-1-ylmethyl)-1,3-oxazolidin-2-one::CHEMBL231481
SMILES: Fc1cc(ccc1-c1ccc(nc1)C(=O)CC1CCNCC1)N1C[C@H](Cn2ccnn2)OC1=O
InChI Key: InChIKey=RGVKJPIMWPUCPK-IBGZPJMESA-N
Data: 1 KI
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Amine oxidase (flavin-containing) A (Homo sapiens (Human)) | BDBM50220013 ((5R)-3-{3-fluoro-4-[6-(piperidin-4-ylacetyl)pyridi...) | PDB UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | 2.80E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca Discovery Curated by ChEMBL | Assay Description Inhibition of human liver MAOA expressed in yeast | J Med Chem 50: 4868-81 (2007) Article DOI: 10.1021/jm070428+ BindingDB Entry DOI: 10.7270/Q2SX6CX0 | |||||||||||
More data for this Ligand-Target Pair |